ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/09/2025
Voltar para busca
Dado oficial do USPTO
A AVANTUM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
04/09/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
44
Data de depósito
23/03/2016
Data de registro
30/04/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/12/2024
Última transação
04/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
31/12/2018
Primeiro uso no comércio
31/12/2018
Código do desenho
5
Tipo de titular
16
Localização do titular
SPRINGFIELD, NJ
Examinador
MAI, TINA
Localização atual
Historical data usage
Descrição da marca
The mark consists of a stylized letter "A" in a distinctive green color, to the right of which is the term "AVANTUM" in all capital letters in gray.
Titulares e representantes
Titulares
ARROW ENVOY HOLDINGS, LLC
TotalCare, LLC
Representantes
Peter E. Nussbaum CHIESA SHAHINIAN & GIANTOMASI PC
Classificação técnica
Classes Nice
Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 44
Institutional pharmacy servicespharmaceutical advice and dispensing pharmaceutical productsprescription drugsmedications to healthcare facilities; Pharmaceutical consultation; Dispensing of pharmaceuticals; Preparation and dispensing of medications; Providing information to patients in the field of administering medications; Maintaining patient medical records for assisted living and long term care facilities and physicians; Providing healthcare and pharmaceutical advice to assisted living and long-term care facilitiestheir residentspatientsphysicians; Providing a web-based system and online portal in the field of pharmacy services for long term care facilities and providersskilled nursing facilitiesassisted living communitiesdoctors and medical providers and their staffpatients and residents to communicate with each other and with pharmacy providers regarding information relating to pharmaceutical dosage information and administration of medication; Providing a web-based system and online portal that allows long term care facilities and providersskilled nursing facilitiesassisted living communitiesdoctors and medical providers and their staffpatients and residents to access medical testing reportsmedicine regimen review and patient medical records to assist in providing health information and for the purpose of monitoring and treating medical conditions and administering medications; Leasing of durable medical equipment; Health care servicesurologicalostomy and skin care and rehabilitation services for nursing home patientsphysical therapyoccupational therapy and speech therapy; Pharmaceutical consulting services provided to entities that care for senior citizens in the field of medication therapy management
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/12/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/12/2024
E815
TEAS SECTION 8 & 15 RECEIVED
09/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
30/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/04/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/03/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/03/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
16/03/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
16/03/2019
IUAF
USE AMENDMENT FILED
26/02/2019
EISU
TEAS STATEMENT OF USE RECEIVED
26/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/09/2018
EX4G
SOU EXTENSION 4 GRANTED
05/09/2018
EXT4
SOU EXTENSION 4 FILED
05/09/2018
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/12/2017
EX3G
SOU EXTENSION 3 GRANTED
08/12/2017
EXT3
SOU EXTENSION 3 FILED
08/12/2017
EEXT
SOU TEAS EXTENSION RECEIVED
08/12/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/08/2017
EX2G
SOU EXTENSION 2 GRANTED
06/08/2017
EXT2
SOU EXTENSION 2 FILED
06/08/2017
EEXT
SOU TEAS EXTENSION RECEIVED
06/08/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/01/2017
EX1G
SOU EXTENSION 1 GRANTED
21/01/2017
EXT1
SOU EXTENSION 1 FILED
21/01/2017
EEXT
SOU TEAS EXTENSION RECEIVED
21/01/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/01/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/09/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2016
PUBO
PUBLISHED FOR OPPOSITION
12/07/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/06/2016
ALIE
ASSIGNED TO LIE
31/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
16/05/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/05/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
16/05/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/05/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2016
DOCK
ASSIGNED TO EXAMINER
07/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/03/2016
NWAP
NEW APPLICATION ENTERED
26/03/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace A AVANTUM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.